StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Corporate ActionJun 26, 2026, 04:36 PM

Z Squared Inc. Registers 100,000 Shares for Resale by Securityholder

AI Summary

Z Squared Inc. (formerly Coeptis Therapeutics Holdings, Inc.) filed an S-1 registration statement for the resale of up to 100,000 shares of common stock by a selling securityholder. These shares are issuable upon the exercise of outstanding warrants at $12.00 per share. The company will not receive proceeds from the resale, but could receive up to $1,200,000 if all warrants are exercised. The filing notes that the resale could adversely affect the market price of its common stock and highlights substantial doubt about the company's ability to continue as a going concern, despite its strategic expansion into AI and high-density compute infrastructure.

Key Highlights

  • Registers up to 100,000 shares of common stock for resale by a selling securityholder.
  • Shares are issuable upon exercise of outstanding warrants at $12.00 per share.
  • Company will not receive proceeds from the resale, but up to $1,200,000 from warrant exercise.
  • The 100,000 shares represent approximately 0.19% of outstanding common stock.
  • Common stock is listed on Nasdaq Global Market under 'ZSQR', closing at $12.20 on June 25, 2026.
  • Company recently completed a business combination on April 24, 2026, changing its name from Coeptis.
  • Independent auditors expressed substantial doubt about the company's ability to continue as a going concern.
  • Company is expanding from digital asset mining into AI and high-density compute infrastructure.